Global Ocular Drug Delivery Technology Market: Based on the technology (Ocular Inserts (Erodible, Non-Erodible), Topical, Intra Ocular Implants (Non-Biodegradable, Bio Degradable), Ionotophoresis, Punctual Plugs and In Situ Gel, Based on the disease indication ( Diabetic Retinopathy, Glaucoma, Macular Degeneration, Cataract, Others, Based on end user (Ambulatory Surgical Centers, Hospitals, Ophthalmic Centers, Others) , and Geography


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Ocular Drug Delivery Technology Market size is valued at USD 16.404 million in 2021 and is expected to reach USD 24.042 million by 2028, at a CAGR of 7.4% during the forecast period 2022-2028. The treatment of ophthalmic illnesses is linked to ocular medicine delivery. Ophthalmic illnesses impact several areas of the eye anatomy, which are primarily divided into anterior and posterior segments based on their location. Ocular medications are applied directly to the affected area or near the affected area to allow for quick absorption and action. For treating anterior eye segment illnesses, topical ocular medication formulations are largely accessible in liquid form, such as solutions, suspensions, and emulsions. More modern procedures, like as implants and injections, are used to treat posterior segment problems. Ophthalmic drug delivery technologies has become most interesting challenging for the scientists due to the unique anatomy, physiology and biochemistry of the eye. Global ocular drug delivery technology market is primarily driven by increase in eye related diseases such as macular degeneration, glaucoma coupled with the preference of the patents and physicians in usage of targeted ocular drug delivery technologies.  this report studies global Market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). 

Ocular Drug Delivery Technology Market Summary

Study Period


Base Year




Largest Market


Fastest Growing Market

Ocular Drug Delivery Technology Market

The low bioavailability of drugs in traditional ocular therapies, an increase in the incidence of glaucoma and macular degeneration, growing demand for targeted ocular drug delivery techniques, and an increase in the number of approvals from government regulations for new ocular drug delivery techniques are the major factors driving the growth of the global ocular drug delivery technology market. Favorable reimbursement rules and increased funding for the development of innovative drug delivery systems may aid market expansion. The solidity of the implants, on the other hand, can cause discomfort, as well as drug dilution, irritation, and severe lachrymation, which could limit market expansion.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Ocular Drug Delivery Technology Market Segmentation

By Technology
  • Ocular Inserts
    • Erodible
    • Non-Erodible
  • Topical
  • Intra Ocular Implants
    • Non-Biodegradable
    • Bio Degradable
  • Ionotophoresis
  • Punctal Plugs (Tear Duct Plugs)
  • In Situ Gel
Disease Idication
  • Diabetic Retinopathy
  • Glaucoma
  • Macular Degeneration
  • Cataract
  • Others
By End User
  • Ambulatory Surgical Centers
  • Hospitals
  • Ophthalmic Centers
  • Others

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

[urltag url='request-table-of-content']

  • Taiwan Liposome Company, Ltd. (Taiwan)
  • Valeant Pharmaceuticals International, Inc. (U.S.)
  • Graybug Vision Inc. (U.S.)
  • Ocular Therapeutix, Inc. (U.S.)
  • Clearside Biomedical, Inc. (U.S.)
  • EyeGate Pharma (U.S.)
  • Alimera Sciences (U.S.)
  • Allergan, Plc (Ireland)
  • Envisia Therapeutics (U.S.)